EUVIMEDObjevte EUVIMED
Crossref

Screening for Wilms tumor and hepatoblastoma in children with Beckwith‐Wiedemann syndromes: A cost‐effective model*

D E McNeil, M Brown, A Ching, M R DeBaun

Medical and Pediatric Oncology · 2001-10 · 37 (4) · 349-356

DOI: 10.1002/mpo.1209 ↗

At a glance

Journal article in Medical and Pediatric Oncology, published online on 2001-09-18. Written by D E McNeil and 3 co-authors. Institution: Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Bethesda, MD 20892-7236, USA. Cited 79 times so far (Crossref); 21 references. Funded by: NCI NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

We undertook a cost‐benefit analysis of screening for Wilms tumor and hepatoblastoma in children with Beckwith‐Wiedemann syndrome (BWS), a known cancer predisposition syndrome. The purpose of this analysis was twofold: first, to assess whether screening in children with BWS has the potential to be cost‐effective; second, if screening appears to be cost‐effective, to determine which parameters would be most important to assess if a screening trial were initiated. Procedures We used data from the BWS registry at the National Cancer Institute, the National Wilms Tumor Study (NWTS), and large published series to model events for two hypothetical cohorts of 1,000 infants born with BWS. One hypothetical cohort was screened for cancer until a predetermined age, representing the base case. The other cohort was unscreened. For our base case, we assumed: (a) sonography examinations three times yearly (triannually) from birth until 7 years of age; (b) screening would result in one stage shift downward at diagnosis for Wilms tumor and hepatoblastoma; (c) 100% sensitivity and 95% specificity for detecting clinical stage I Wilms tumor and hepatoblastoma; (d) a 3% discount rate; (e) a false positive result cost of $402. We estimated mortality rates based on published Wilms tumor and hepatoblastoma stage specific survival.

Results

Using the base case, screening a child with BWS from birth until 4 years of age results in a cost per life year saved of $9,642 while continuing until 7 years of age results in a cost per life‐year saved of $14,740. When variables such as cost of screening examination, discount rate, and effectiveness of screening were varied based on high and low estimates, the incremental cost per life‐year saved for screening up until age four remained comparable to acceptable population based cancer screening ranges (< $50,000 per life year saved).

Conclusions

Under our model's assumptions, abdominal sonography examinations in children with BWS represent a reasonable strategy for a cancer screening program. A cancer screening trial is warranted to determine if, when, and how often children with BWS should be screened and to determine cost‐effectiveness in clinical practice. Med Pediatr Oncol 2001;37:349–356. Published 2001 Wiley‐Liss, Inc.

Subjects

MeSH terms (MEDLINE)

Age DistributionBeckwith-Wiedemann SyndromeChildChild, PreschoolCohort StudiesComorbidityCost-Benefit AnalysisFemaleHepatoblastomaHumansInfantKidney NeoplasmsLiver NeoplasmsMaleMass ScreeningRegistriesSensitivity and SpecificitySex DistributionSurvival AnalysisUltrasonography

Authors and institutions

  • Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Bethesda, MD 20892-7236, USA.

Funding

  • NCI NIH HHS

Cite

APA

McNeil, D. E., Brown, M., Ching, A., & DeBaun, M. R. (2001). Screening for Wilms tumor and hepatoblastoma in children with Beckwith‐Wiedemann syndromes: A cost‐effective model*. Medical and Pediatric Oncology, 37(4), 349-356. https://doi.org/10.1002/mpo.1209

Vancouver

McNeil DE, Brown M, Ching A, DeBaun MR. Screening for Wilms tumor and hepatoblastoma in children with Beckwith‐Wiedemann syndromes: A cost‐effective model*. Medical and Pediatric Oncology. 2001;37(4):349-356. doi:10.1002/mpo.1209

BibTeX
@article{McNeil2001,
  author = {McNeil, D E and Brown, M and Ching, A and DeBaun, M R},
  title = {Screening for Wilms tumor and hepatoblastoma in children with Beckwith‐Wiedemann syndromes: A cost‐effective model*},
  journal = {Medical and Pediatric Oncology},
  year = {2001},
  volume = {37},
  number = {4},
  pages = {349--356},
  doi = {10.1002/mpo.1209}
}
Start for free →